IL4 and myeloid sarcoma: In the case of EAE, a model of MS, studies demonstrate that the delivery of DNA vaccine with the self-peptide PLP139-151 and IL-4 protected against induction of the disease induced by PLP139-151 and caused that the antigen-specific autoreactive T cells shift their phenotype to a protective TH2-type response [37].